Form 8-K - Current report:
SEC Accession No. 0001683168-21-002921
Filing Date
2021-07-13
Accepted
2021-07-12 19:16:31
Documents
6
Period of Report
2021-07-09
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K pharmacyte_8k.htm 8-K 19123
2 CERTIFICATE OF CHANGE pharmacyte_ex9901.htm EX-99.1 2907
3 PRESS RELEASE pharmacyte_ex9902.htm EX-99.2 14168
4 GRAPHIC image_004.jpg GRAPHIC 43785
5 GRAPHIC image_005.jpg GRAPHIC 78555
6 GRAPHIC image_001.jpg GRAPHIC 5190
  Complete submission text file 0001683168-21-002921.txt   213532
Mailing Address 23046 AVENIDA DE LA CARLOTA, SUITE 600 LAGUNA HILLS CA 92653
Business Address 23046 AVENIDA DE LA CARLOTA, SUITE 600 LAGUNA HILLS CA 92653 (917) 595.2850
PharmaCyte Biotech, Inc. (Filer) CIK: 0001157075 (see all company filings)

EIN.: 621772151 | State of Incorp.: NV | Fiscal Year End: 0430
Type: 8-K | Act: 34 | File No.: 333-68008 | Film No.: 211086443
SIC: 2836 Biological Products, (No Diagnostic Substances)